Published in Lab Invest on June 01, 1995
HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J (1998) 10.08
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest (1999) 6.32
Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol (1998) 3.62
Vascular endothelial growth factor in eye disease. Prog Retin Eye Res (2008) 2.73
Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol (1997) 2.73
Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A (1996) 2.67
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol (2000) 2.41
Microvascular patterning is controlled by fine-tuning the Akt signal. Proc Natl Acad Sci U S A (2004) 2.39
Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol (1997) 2.28
Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy. J Ocul Pharmacol Ther (2013) 2.20
Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest (1998) 1.85
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest (1996) 1.76
Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol (1998) 1.61
Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol (2002) 1.59
Vascular endothelial growth factor and ocular neovascularization. Am J Pathol (1997) 1.56
Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol (1997) 1.44
VEGF localisation in diabetic retinopathy. Br J Ophthalmol (1998) 1.40
Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol (1999) 1.34
Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.29
Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol (1997) 1.29
VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res (2007) 1.25
Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol (1998) 1.20
Astrocyte-derived vascular endothelial growth factor stabilizes vessels in the developing retinal vasculature. PLoS One (2010) 1.11
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion. Cochrane Database Syst Rev (2014) 1.09
Alteration of developmental and pathological retinal angiogenesis in angptl4-deficient mice. J Biol Chem (2011) 1.05
Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy. Br J Ophthalmol (1999) 1.05
Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol (1997) 1.04
Calpain inhibitors reduce retinal hypoxia in ischemic retinopathy by improving neovascular architecture and functional perfusion. Biochim Biophys Acta (2010) 1.03
Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion. Cochrane Database Syst Rev (2010) 1.00
Angiogenic factors in human proliferative sickle cell retinopathy. Br J Ophthalmol (1999) 1.00
Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases. Invest Ophthalmol Vis Sci (2006) 0.99
Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye. PLoS One (2011) 0.95
Vascular endothelial growth factor. The trigger for neovascularization in the eye. Lab Invest (1995) 0.94
Inhibition of retinal neovascularization by siRNA targeting VEGF(165). Mol Vis (2008) 0.93
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture. J Ophthalmol (2011) 0.92
Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future. Br J Clin Pharmacol (2014) 0.89
Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor. Invest New Drugs (1999) 0.88
Anti-angiogenic effect of KH902 on retinal neovascularization. Graefes Arch Clin Exp Ophthalmol (2013) 0.85
Targeting Neovascularization in Ischemic Retinopathy: Recent Advances. Expert Rev Ophthalmol (2013) 0.84
Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series. J Ocul Biol Dis Infor (2009) 0.84
Moderate GSK-3β inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy. Angiogenesis (2010) 0.84
Suppression of retinal neovascularization by lentivirus-mediated netrin-1 small hairpin RNA. Ophthalmic Res (2011) 0.83
Mitochondrial responses to extreme environments: insights from metabolomics. Extrem Physiol Med (2015) 0.83
Robust hypoxia-selective regulation of a retinal pigment epithelium-specific adeno-associated virus vector. Mol Vis (2008) 0.83
Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice. Graefes Arch Clin Exp Ophthalmol (2005) 0.81
ERK5 Contributes to VEGF Alteration in Diabetic Retinopathy. J Ophthalmol (2010) 0.80
Vascular endothelial growth factors and their inhibitors in ocular neovascular disorders. J Ophthalmic Vis Res (2009) 0.80
Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration. Core Evid (2008) 0.80
N-CAM exhibits a regulatory function in pathological angiogenesis in oxygen induced retinopathy. PLoS One (2011) 0.79
Early Avastin management in acute retinal vein occlusion. Saudi J Ophthalmol (2010) 0.79
ERK5 Mediated Signalling in Diabetic Retinopathy. Med Hypothesis Discov Innov Ophthalmol (2015) 0.76
Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma. Trans Am Ophthalmol Soc (2016) 0.75
The effect of intravitreal vascular endothelial growth factor on inner retinal oxygen delivery and metabolism in rats. Exp Eye Res (2015) 0.75
VEGF mRNA and protein concentrations in the developing human eye. Pediatr Res (2015) 0.75
Short term apoptotic activity of intravitreal bevacizumab on rabbit retina. Int J Ophthalmol (2013) 0.75
Triamcinolone and bevacizumab as adjunctive therapies to panretinal photocoagulation for proliferative diabetic retinopathy. ISRN Ophthalmol (2012) 0.75
Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration. Int J Retina Vitreous (2017) 0.75
Role of endogenous insulin gene enhancer protein ISL-1 in angiogenesis. Mol Vis (2016) 0.75
Role of vascular endothelial growth factor in the breakdown of the blood-aqueous barrier after retinal laser photocoagulation in pigmented rabbits. J Ocul Pharmacol Ther (2011) 0.75
Effects of alpha-lipoic acid on retinal ganglion cells, retinal thicknesses, and VEGF production in an experimental model of diabetes. Int Ophthalmol (2016) 0.75
Rho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases. J Ophthalmol (2017) 0.75
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (1992) 18.26
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (1998) 11.61
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med (1995) 7.88
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest (1999) 6.32
A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development (1998) 5.91
Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci (1995) 4.97
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85
Effect of CpG methylation on Msp I. Nucleic Acids Res (1983) 4.32
Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol (1998) 3.62
Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol (1995) 2.99
Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A (1995) 2.94
Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc Natl Acad Sci U S A (1998) 2.92
Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res (1994) 2.91
Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci U S A (1997) 2.86
Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA. J Virol (1979) 2.33
Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A (1990) 2.25
Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci (1996) 2.24
VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem (1997) 2.12
Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest (1993) 2.07
A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development (2001) 1.92
Sites of integration of reticuloendotheliosis virus DNA in chicken DNA. Proc Natl Acad Sci U S A (1978) 1.86
Heterogeneity of "virus-like" genes encoding retrovirus-associated 30S RNA and their organization within the mouse genome. Cell (1980) 1.85
Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes. Proc Natl Acad Sci U S A (1981) 1.72
DNA of noninfectious and infectious integrated spleen necrosis virus (SNV) is colinear with unintegrated SNV DNA and not grossly abnormal. Cell (1979) 1.71
Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology (1998) 1.68
Patterns of genomic distribution and sequence heterogeneity of a murine "retrovirus-like" multigene family. J Virol (1982) 1.61
Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res (1997) 1.59
Lack of benefit of early awareness to age-related macular degeneration. Eye (Lond) (2007) 1.57
Purification of the insulin receptor from human placenta by chromatography on immobilized wheat germ lectin and receptor antibody. J Biol Chem (1980) 1.54
Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity. Br J Ophthalmol (2001) 1.39
Terminal direct repeats in a retrovirus-like repeated mouse gene family. Nature (1981) 1.31
Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.29
Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am J Physiol Cell Physiol (2001) 1.27
In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci U S A (1992) 1.23
Correlation of transient accumulation of linear unintegrated viral DNA and transient cell killing by avian leukosis and reticuloendotheliosis viruses. Cold Spring Harb Symp Quant Biol (1980) 1.23
In vivo angiogenic activity of interleukins. Arch Ophthalmol (1990) 1.23
Nucleotide sequence analysis of the long terminal repeat of murine virus-like DNA (VL30) and its adjacent sequences: resemblance to retrovirus proviruses. J Virol (1983) 1.22
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. FASEB J (2000) 1.18
Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription. J Virol (1990) 1.15
Detection and characterization of hepatitis B virus DNA in serum of HBe antigen-negative HBsAg carriers. J Med Virol (1984) 1.14
Mouse retrotransposons: a cellular reservoir of long terminal repeat (LTR) elements with diverse transcriptional specificities. Adv Cancer Res (1991) 1.09
A novel retroviruslike family in mouse DNA. J Virol (1986) 1.08
Nucleotide sequences derived from pheasant DNA in the genome of recombinant avian leukosis viruses with subgroup F specificity. J Virol (1977) 1.07
Diverse long terminal repeats are associated with murine retroviruslike (VL30) elements. Mol Cell Biol (1986) 1.07
Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci U S A (1997) 1.06
Apparent recombinants between virus-liKE (VL30) and murine leukemia virus-related sequences in mouse DNA. J Virol (1983) 1.05
Rubeosis iridis in retinoblastoma. Histologic findings and the possible role of vascular endothelial growth factor in its induction. Ophthalmology (1997) 1.04
'Solo' large terminal repeats (LTR) of an endogenous retrovirus-like gene family (VL30) in the mouse genome. Nucleic Acids Res (1984) 1.01
Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Lett (1998) 1.00
Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest (1990) 1.00
Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea (1994) 0.98
Analysis of mouse embryonic gene library for the frequency of single and multiple copy genes. Mol Biol Rep (1980) 0.97
Ischemia-driven angiogenesis. Trends Cardiovasc Med (1997) 0.96
Glandular tumors of the lacrimal sac. Their histopathologic patterns and possible origins. Ophthalmology (1996) 0.96
Cloning of bovine growth hormone gene and its expression in bacteria. Nucleic Acids Res (1981) 0.94
Primer binding sites corresponding to several tRNA species are present in DNAs of different members of the same retrovirus-like gene family (VL30). J Virol (1985) 0.92
Prevalence of clinical asymptomatic retinal detachment in myopic population. Br J Ophthalmol (2008) 0.92
Conjunctival oculosporidiosis in east Africa caused by Rhinosporidium seeberi. Arch Pathol Lab Med (1996) 0.92
Studies of the mechanism of spontaneous germline ecotropic provirus acquisition in mice. EMBO J (1988) 0.92
The testis-specific transcript (ferT) of the tyrosine kinase FER is expressed during spermatogenesis in a stage-specific manner. Mol Cell Biol (1990) 0.92
PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups. Ophthalmology (1994) 0.92